Identity & origin
BOTANICAL IDENTITY
The right name is the first step.
Kew describes this taxon as a tree. This notice concerns Phyllanthus emblica, family Phyllanthaceae. The pharmacopoeial material is: fruits.
Results are presented to explain the research; no self-medication recommendation.
Also known as: Phyllanthus, Phyllanthus emblica
Amla is the fruit of Phyllanthus emblica. Multi-herb products containing it do not allow a result to be attributed to this fruit alone.A photograph alone does not guarantee identification for consumption.
An illustration is not enough to identify a plant for consumption. Do not forage for a species based solely on this profile.
Uses & evidence
UNDERSTANDING THE USES
Properties & uses.
Hypertension: no additional benefit in a trial
A trial of amla extract added to usual medicines produced no additional blood-pressure reduction.
A human study may be positive, negative or inconclusive. Read the findings, preparation and limitations.
Read the sourceThe traditional uses described are not clinical proof of effectiveness. Evidence for one preparation cannot automatically be applied to another.
Precautions before use
BEFORE ANY USE
Precautions & contraindications.
This guidance does not cover every individual situation. Missing information is not a guarantee of safety.
Contraindications & precautions
- Insufficient dataThis targeted audit does not provide a comprehensive contraindication review; this does not mean contraindications are absent.
Medicine interactions
- Insufficient dataThis dossier cannot establish compatibility with medication. A limited study does not replace an interaction review of the exact product.
Other retained warnings · review incomplete
These existing warnings remain relevant to consult. Their exhaustive reassessment is outside this targeted review.
Restrictions and precautions
- The references in this notice do not establish a complete contraindication list. This limitation does not mean absence of risk.
Medicine interactions
- Medicine compatibility is not assessed in this notice; a pharmacist should check it before any use.
Pregnancy, breastfeeding and children
The retained data do not support recommending medicinal use during pregnancy or breastfeeding.
No paediatric use is proposed; pharmacopoeial listing does not establish a child-appropriate dose.
“Reported” does not prove causality; “possible” may reflect indirect evidence. “None reported” means none in the cited source, not that all combinations have been studied. Do not stop a prescribed treatment based on this profile.
Adverse effects
- Trial size and duration cannot rule out rare or delayed effects. Tolerability of the tested product does not apply to every preparation.
Pregnancy & breastfeeding
The retained data do not support recommending medicinal use during pregnancy or breastfeeding.
Children & adolescents
No paediatric use is proposed; pharmacopoeial listing does not establish a child-appropriate dose.
If symptoms persist, worsen or are unusual, consult a healthcare professional. In an emergency, contact the emergency services.
Available evidence
EXPLORE THE EVIDENCE
The available evidence.
A trial of amla extract added to usual medicines produced no additional blood-pressure reduction.
Hypertension: no additional benefit in a trial
The results did not show the intended additional antihypertensive effect.
A human study may be positive, negative or inconclusive. Read the findings, preparation and limitations.
Read the referenceLimitations to keep in mind.
Do not buy an extract to replace or independently intensify blood-pressure treatment.
Studies, findings & limitations
THE RESEARCH
What the research shows.
A laboratory or animal result alone does not demonstrate a benefit in humans. Each result must be read alongside the preparation studied and its limitations.
Hypertension: no additional benefit in a trial
A human study may be positive, negative or inconclusive. Read the findings, preparation and limitations.
- Type of research
- Double-blind randomized trial, 150 patients, twelve weeks.
- Preparation concerned
- Aqueous fruit extract in capsules added to care.
- Observed results
- No advantage was observed for the other main metabolic measures studied.
- Limitations to consider
- This concerns the tested formulation and indication; nutrient composition alone cannot override a clinical result.
What can we take from this?
This concerns the tested formulation and indication; nutrient composition alone cannot override a clinical result.
Documentary review dated 09/10/2026. The references remain available to check the context.
Sources & last review
CHECKING REFERENCES
Sources for this profile.
- ANSM — French Pharmacopoeia, List A, January 2026, p. 28Accessed on 09/10/2026
- GBIF — taxonomy of Phyllanthus emblicaAccessed on 09/10/2026
- Kew POWO — Phyllanthus emblica L.Accessed on 09/10/2026
- Antihypertensive and pleiotropic effects of Phyllanthus emblica extract as an add-on therapy in patients with essential hypertension-A randomized double-blind placebo-controlled trial. — Shanmugarajan D et al. (2021)Accessed on 09/10/2026
Image: Raja Sekhar Chimirala · CC BY 4.0. View the original image and its licence. Image resized and converted to WebP.